Competition & Peer Data API & CSV Delivery

Biospecifics Technologies's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Biospecifics Technologies (BSTC) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2020
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
19.21 %
Q3 2020
Net Margin
47.86 %
Q3 2020

Key Findings: Biospecifics Technologies vs Its Competitors

  • TTM: Trailing 12-month revenue of 37M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+23.0% annualized vs trailing 12 months).
  • Peer revenue share: Biospecifics Technologies accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

BSTC Sales vs. its Competitors, Q3 2020

Biospecifics Technologies generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/BSTC/competitors
https://api.csimarket.com/api/v1/companies/BSTC/relationships
https://api.csimarket.com/api/v1/companies/BSTC/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Major Pharmaceutical Preparations industry grew revenue 7.2% year over year, combined, vs 19.2% for Biospecifics Technologies. Biospecifics Technologies's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Biospecifics Technologies's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Biospecifics Technologies Corp Yes No No Yes
Similar Growth & Profitability (8) 100.00 % (8 of 8) 100.00 % (8 of 8) 75.00 % (6 of 8) 0.00 % (0 of 6)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q3 2020

100%market share
  • Biospecifics Technologies100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Biospecifics Technologies and its 0 tracked competitors.

See Biospecifics Technologies's full market share breakdown »

BSTC Stock Performance relative to its Competitors

BSTC Competitors (weighted) Percent change over the selected range

BSTC Stock Performance relative to Similar Growth & Profitability Competitors

BSTC Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range